At the institute’s Cancer Early Detection Advanced Research Center, Dr. Heller will develop techniques and instruments to diagnosis and examine early signs of cancer. In the past two years, the research center has hired more than 20 people for engineering, biology, informatics and computer science roles, according to Portland Business Journal.
At UC San Diego, Dr. Heller established a bioengineering and nanobiology laboratory and developed biochips that analyze blood for bioindicators of cancer, Portland Business Journal reports. Prior, he co-founded and served as chief technology officer of the diagnostics company Nanogen.
More articles on health IT:
mHealth interventions reduce blood pressure, study finds
Huntington’s Disease Society taps American Well for remote psychology, social work
Dementia apps lack privacy, study finds
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.